Pictet Asset Management Holding Sa Akero Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 314,711 shares of AKRO stock, worth $14.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
314,711Holding current value
$14.9 Million% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
275Shares Held
85.7MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$352 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$336 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$282 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$265 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$249 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.2B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...